Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

NCT00629018 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Dilated Cardiomyopathy

Interventions

BIOLOGICAL: CD34+ autologous stem cell transplantation
DRUG: Bone Marrow Stimulation
BIOLOGICAL: SC therapy

Sponsor

University Medical Centre Ljubljana

Collaborators

[object Object]
[object Object]